Negócios · 13/09/20001 min de leitura
Lilly Research Laboratories et al.; Withdrawal of Approval of 28 New Drug Applications
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is withdrawing approval of 28 new drug applications (NDA's). The holders of the applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.